Home Data Calendar Blog

ZNTL

Tables

		2024-03-31
Common Stock Value		0.07
Weighted Average Number Of Diluted Shares Outstanding		71.19
Weighted Average Number Of Shares Outstanding Basic		70.90
Earnings Per Share Basic		0.14
Earnings Per Share Diluted		0.14

		2024-03-31
Revenue From Contract With Customer Excluding Assessed Tax		40.56
Revenues		40.56
Operating Expenses		65.33
Research And Development Expense		49.59
General And Administrative Expense		15.74
Operating Income Loss		-24.77
Allocated Share Based Compensation Expense		12.83
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments		10.18
Income Tax Expense Benefit		0.14
Profit Loss		10.04
Net Income Loss		10.07
Comprehensive Income Net Of Tax		8.65

		2024-03-31
Assets		557.48
Liabilities		98.71
Liabilities And Stockholders Equity		557.48
Stockholders Equity		458.77

		2024-03-31
Assets Current		503.81
Cash And Cash Equivalents At Carrying Value		37.62
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		40.30
Prepaid Expense And Other Assets Current		14.82
Available For Sale Securities Debt Securities		394.64

		2024-03-31
Property Plant And Equipment Gross		9.08
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		3.40
Property Plant And Equipment Net		5.68
Available For Sale Debt Securities Amortized Cost Basis		393.87
Held To Maturity Securities Debt Maturities Within One Year Fair Value		255.96

		2024-03-31
Liabilities Current		54.80
Accounts Payable Current		10.50
Accrued Income Taxes Current		0.40
Accrued Liabilities Current		44.30

		2024-03-31
Minority Interest		NA
Other Liabilities Noncurrent		1.29
Operating Lease Liability Noncurrent		42.62

		2024-03-31
Stockholders Equity		458.77
Stockholders Equity Including Portion Attributable To Noncontrolling Interest		458.77
Common Stock Value		0.07
Additional Paid In Capital		1336.42
Retained Earnings Accumulated Deficit		-878.49
Accumulated Other Comprehensive Income Loss Net Of Tax		0.77
Minority Interest		NA
Stock Issued During Period Value New Issues		NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		12.83

		2024-03-31
Net Cash Provided By Used In Operating Activities		-51.97
Net Cash Provided By Used In Investing Activities		61.55
Net Cash Provided By Used In Financing Activities		0.01

		2024-03-31
Net Cash Provided By Used In Operating Activities		-51.97
Net Income Loss		10.07
Profit Loss		10.04
Depreciation Depletion And Amortization		0.32
Share Based Compensation		12.83

		2024-03-31
Net Cash Provided By Used In Investing Activities		61.55
Payments To Acquire Property Plant And Equipment		0.04

		2024-03-31
Net Cash Provided By Used In Financing Activities		0.01

		2024-03-31
Revenues		40.56
Immunome Inc		40.60
Revenue From Contract With Customer Excluding Assessed Tax		40.56
Immunome Inc		40.60

Plots across concepts

Line plots across dimensions of each concept